Metabolic dysfunction and metformin modify plasma extracellular vesicle signaling to prostate cancer cells
Michael Seen, Pablo Llévenes, Heejoo Kang, Yuhan Qiu, Christina S. Ennis, Andrew Chen, Sara M. Alexanian, Devin Steenkamp, Stefano Monti, Gerald V. Denis
This study investigates how metabolic dysfunction and metformin affect plasma extracellular vesicle signaling to prostate cancer cells, identifying specific miRNAs and their effects on tumor progression.
bioRxiv · Nov 1, 2026 · PreprintCancer Biology